Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ · Healthcare
Rigel Pharmaceuticals, Inc. Long Term Debt 2016–2025
Rigel Pharmaceuticals, Inc. annual long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Rigel Pharmaceuticals, Inc. long term debt as of December 31, 2025: 52.5M, a 12.50% decrease year-over-year.
- Rigel Pharmaceuticals, Inc. long term debt for 2025 were 52.5M, a 12.50% decrease from 2024.
- Rigel Pharmaceuticals, Inc. long term debt for 2024 were 60.0M, a 0.00% increase from 2023.
- Rigel Pharmaceuticals, Inc. long term debt for 2023 were 60.0M, a 50.00% increase from 2022.
- Rigel Pharmaceuticals, Inc. long term debt for 2022 were 40.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Rigel Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $53 |
| 2024 | $60 |
| 2023 | $60 |
| 2022 | $40 |
| 2021 | $20 |
| 2020 | $20 |
| 2019 | $10 |
Rigel Pharmaceuticals, Inc. Long Term Debt — FAQ
Rigel Pharmaceuticals, Inc. (RIGL) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RIGL's long term debt history?
The chart and table above show Rigel Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.